Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ACI-35 Alzheimer's Disease (Phase 1) AC Immune SA, Janssen Tau Immunotherapy (active)
AL002 Alzheimer's Disease (Phase 1) AbbVie, Alector Inflammation Immunotherapy (active)
AL003 Alzheimer's Disease (Phase 1) AbbVie, Alector Inflammation Immunotherapy (active)
Lu AF20513 Alzheimer's Disease (Phase 1) H. Lundbeck, Otsuka Pharmaceutical Co., Ltd. Amyloid-Related Immunotherapy (active)